Where does ImmunSys, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), ImmunSys, Inc. ranks #40,869 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does ImmunSys, Inc. hold?

ImmunSys, Inc. holds 6 US utility patents granted between 2020 and 2025, spanning 6 technology areas.

What is ImmunSys, Inc.'s Innovation Score?

ImmunSys, Inc. has an Innovation Score of 40.4 out of 100 (top 36% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does ImmunSys, Inc. focus on?

ImmunSys, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 6 patents. Grants appear in 6 CPC subclasses total.

Is ImmunSys, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for ImmunSys, Inc..

What does claim depth mean for ImmunSys, Inc.'s patents?

ImmunSys, Inc.'s patents average 27.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the ImmunSys, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

ImmunSys, Inc.

USPTO PatentsView assignee record - 6 granted patents across 6 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Immunsys ranks #40,869 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 6 technology areas.

#40,869
of 49,997 US assignees by volume: Top 36%
by Innovation Score (40.4/100): 27.2
avg claims per patent

USPTO PatentsView assignee plate

Corpus R40869 · US Corporation #40,869 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 6 grants
LOWER-Q #40,869/49,997
PHOTO-FINISH Idesyn Semiconductor
CPC-NARROW A61B · 6 areas
INNOV-PAR 40.4/100
CLAIMS-DENSE 27.2 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Idesyn Semiconductor Corp. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
ImmunSys · this assignee

40
3D Lighting… · lowest

7

What this shows Immunsys's Innovation Score is 40.4/100 (top 36% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Immunsys's grants concentrate

ImmunSys, Inc. is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2023 (2 grants) versus a trough of 1 in 2020. By volume, Immunsys sits between Idesyn Semiconductor Corp. and Improved Racing Products, LLC.

Immunsys's three-year grant acceleration

ImmunSys, Inc. shows 3 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Idesyn Semiconduc…

6
Ignition Interfac…

6
Ilion Medical

6
Illinois Grain &…

6
Imnate Sarl

6
Impossible Diamond

6
Impress Group B V

6
Improved Racing P…

6
Immunsys ◀

6

What this shows ImmunSys holds 6 patents at rank #40,957, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near ImmunSys

By rank, the assignees closest to #40,957 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in ImmunSys's primary technology class.

Immunsys's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 36% higher than 64% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

ImmunSys, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	1	16.7%
2021	1	16.7%
2022	1	16.7%
2023	2	33.3%
2025partial year	1	16.7%

Which technologies does ImmunSys, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 6

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 5

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 3

C07K - Peptides 2

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 2

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

Top 6 of 6 technology areas

Where it ranks

Overall rank by patents

#40,869

of 49,997 tracked assignees

Innovation Score

40.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

ImmunSys, Inc.'s patent record in context - here's where to go next.

ImmunSys, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #40,869 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare ImmunSys, Inc. against Idesyn Semiconductor Corp., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.